BioCentury

12:57 AM GMT, Oct 18, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Covagen, Mitsubishi in deal for bispecific FynomAbs

Covagen AG (Zurich, Switzerland) will use its Fynomer protein engineering technology to develop bispecific

Read the full 147 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.